Cargando…
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action
Conventional chemotherapeutic agents are often toxic not only to tumor cells but also to normal cells, limiting their therapeutic use in the clinic. Novel natural product anticancer compounds present an attractive alternative to synthetic compounds, based on their favorable safety and efficacy profi...
Autores principales: | Nag, Subhasree Ashok, Qin, Jiang-Jiang, Wang, Wei, Wang, Ming-Hai, Wang, Hui, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289390/ https://www.ncbi.nlm.nih.gov/pubmed/22403544 http://dx.doi.org/10.3389/fphar.2012.00025 |
Ejemplares similares
-
Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
por: Voruganti, Sukesh, et al.
Publicado: (2015) -
KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology
por: Wang, Wei, et al.
Publicado: (2012) -
Natural Product Ginsenoside 25-OCH(3)-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
por: Wang, Wei, et al.
Publicado: (2012) -
Brain Transport Profiles of Ginsenoside Rb(1) by Glucose Transporter 1: In Vitro and in Vivo
por: Wang, Yu-Zhu, et al.
Publicado: (2018) -
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2014)